Balyasny Asset Management’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-130,914
Closed -$418K 2052
2024
Q4
$418K Buy
+130,914
New +$418K ﹤0.01% 1528
2024
Q2
Sell
-11,172
Closed -$133K 1968
2024
Q1
$133K Buy
+11,172
New +$133K ﹤0.01% 1854